VIVUS Blows Out Estimates, but Qsymia Units Drop Sequentially - 24/7 Wall St.Bidness EtcVIVUS Blows Out Estimates, but Qsymia Units Drop Sequentially24/7 Wall St.VIVUS Inc. (NASDAQ: VVUS) is going to have to explain how its diet pill Qsymia had lower prescription volumes sequentially. If you just look at the revenue number, it looks massively higher at $36.7 million versus the $11.4 million expected. The ...Vivus Earnings On TapSeeking AlphaVivus Earnings Surprise Pushes Up Stock PriceBidness Et...For more info visit my blog HERE
No comments:
Post a Comment